Except for historical information, this summary annual report contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning industry outlook, including market acceptance of or transition to new products or technology such as intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), software, and advanced X-ray products; growth drivers; our orders, sales, backlog, or earnings growth; future financial results and any statements using the terms “expect,” “should,” “will,” “position,” “point,” “potential,” “continue,” or similar statements are forward-looking statements that involve risks and uncertainties that could cause our actual results to differ materially from those anticipated. Such risks and uncertainties include, without limitation, demand for our products; our ability to develop and commercialize new products; the impact of competitive products and pricing; the effect of economic conditions and currency exchange rates; our ability to meet demand for manufacturing capacity; the effect of environmental claims and expenses; our ability to protect our intellectual property; the impact of managed care initiatives or other healthcare reforms on capital expenditures and/or third-party reimbursement levels; our ability to meet U.S. FDA and other regulatory requirements or product clearances; our dependency on a small number of customers for a significant amount of our sales; our reliance on a limited group of suppliers, and in some cases sole source suppliers, for some product components; the potential loss of key distributors; the possibility that material product liability claims could harm future sales or require us to pay uninsured claims; the risk of operations interruptions due to events beyond our control; and other risks detailed from time to time in our filings with the Securities and Exchange Commission. We assume no obligation to update or revise any forward-looking statements because of new information, future events, or otherwise.

Acuity, BrachyVison, CadPlan PLUS, Eclipse, Exact, EXaCT Targeting, Dynamic Targeting, Generation 6, Helios, Millennium, PortalVison, RPM, Silhouette, SmartBeam, Snowbird, Twister, VariSeed, VariSource, Vitesse, and Vision are trademarks of Varian Medical Systems, Inc.

CadPlan, Clinac, GammaMed, Linatron, PaxScan, See & Treat Cancer Care, Varian, Varian Medical Systems, VARiS, and Ximatron are registered trademarks of Varian Medical Systems, Inc.